5/30/2008

Glenmark Pharmaceuticals unit Glenmark Generics has secured final approval from the FDA for new strengths of mometasone furoate topical treatments, as well as new dosages of metformin hydrochloride tablets -- the generic version of Bristol-Myers Squibb Co.'s diabetes drug Glucophage. The products will be launched in the U.S. soon, the Indian drug firm said.

Related Summaries